Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults
Keywords: AEs; adverse events; ATP; according-to-protocol; CIs; confidence intervals; CMI; cell-mediated immune; COPD; chronic obstructive pulmonary disease; EU; ELISA units; GMCs; geometric mean concentrations; GMTs; geometric mean titers; ICS; intracellular cytok